KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹212 Cr | ₹236 Cr | ₹225 Cr | ₹187 Cr | ₹154 Cr |
What is the latest Total Non-Current Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹212 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹225 Cr |
| Mar2022 | ₹187 Cr |
| Mar2021 | ₹154 Cr |
How is Total Non-Current Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹212 Cr | -10.11 | |
| Mar2024 | ₹236 Cr | 4.53 | |
| Mar2023 | ₹225 Cr | 20.61 | |
| Mar2022 | ₹187 Cr | 21.51 | |
| Mar2021 | ₹154 Cr | - | |
Compare Total Non-Current Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹131.5 Cr | 3.3% | 13.8% | -28.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 3.3% |
13.8% |
-28.2% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses